Metraipolis › archive › dc_2d63ba3cc14b

Therapeutic antibody delivery: vector tools to boost efficacy and affordability — Europe PMC PMID:41573565

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41573565
DOI
10.3389/fimmu.2025.1714390
License (as archived)
solo-consultazione
Archived
2026-11-07T00:04:16.703Z
SHA-256 of the archived text
d515efef5b99a5dc374f37564a7531970298d1427e88b5bdd0cddf11b123ec74
Stable URL of this page
https://metraipolis.com/documento/dc_2d63ba3cc14b

How to cite

Therapeutic antibody delivery: vector tools to boost efficacy and affordability — Europe PMC PMID:41573565 — Europe PMC (en), https://europepmc.org/article/MED/41573565 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2d63ba3cc14b (Metraipolis archive dc_2d63ba3cc14b, sha256 d515efef5b99a5dc374f37564a7531970298d1427e88b5bdd0cddf11b123ec74)
BibTeX
@misc{dc2d63ba3cc14b,
  title = {Therapeutic antibody delivery: vector tools to boost efficacy and affordability — Europe PMC PMID:41573565},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41573565},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2d63ba3cc14b; sha256 d515efef5b99a5dc374f37564a7531970298d1427e88b5bdd0cddf11b123ec74},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41573565. Agents can read the archived copy with the MCP tool read_document.